Donwha receives presidential award for DW-1350

Published: 2008-12-17 06:41:00

Updated: 2008-12-17 06:41:00

Dongwha Pharm said on November 11 that following DW224a (zabofloxacin), it received, for the consecutive two years, the Presidential Award in 2008 Health Industry and Technology Exhibition of Korea (HITEK) in recognition for developing and exporting a newly developed substance for a drug to cure osteoporosis, called DW1350,

Hosted by the Ministry of health and Welfare and Korea Health Indus...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.